President

Fabio Badilini
AMPS LLC 

Fabio Badilini received a master degree in Biomedical Engineering at the Politecnico University of Milan, Italy in 1989. In 1994, he received doctoral degree in Electrical Engineering from the University of Rochester, NY.

Since 2018, Dr. Badilini is a full professor at the University of California of San Francisco (UCSF) where he directs the Center for Physiologic Research, a laboratory established to focus on the analysis of waveform data from intensive care units, aiming to solve the problem of “fatigue” caused by the large number false positive cardiac alarms generated by bedside monitoring systems.

Vice-President

GE Healthcare

Brian Young is the Director of Algorithms, Clinical and Usability Engineering at GE Healthcare in the Diagnostic Cardiology division of the of Patient Care Solutions business. He has a BS degree in Biomedical engineering and MS degree in Electrical Engineer from Marquette University, He has over 40 years of experience in development of computerized ECG algorithms, ECG systems, clinical workflow solutions, user experience designs, and other cardiovascular technologies. He has held leadership roles across multiple teams and disciplines that are focused on advancement and innovation in the field of electrocardiology.

Brian has dedicated over 35 years of his career to the field of electrocardiography, starting with Marquette Electronics before it was acquired by General Electric. He has authored or co-authored many peer-reviewed publications and has been granted many international patents and has several still pending. He currently serves as Co-Chair of the AAMI ECG Committee, is a US National Expert on the ISO/IEC Joint Work Group 22 and is the AAMI Co-Chair of the US 62D Technical Advisory Group for Electromedical Equipment.

Secretary

Dr. Jessica Zègre-Hemsey is an associate professor with expertise in emergency cardiac care. Her research is focused on improving outcomes for individuals with acute coronary syndrome (ACS), and other time-sensitive cardiovascular conditions.

In her current research, Dr. Zègre-Hemsey investigates (1) cardiac monitoring (electrocardiography) and other non-invasive physiological measures, and (2) implementation of evidence-based innovations into prehospital and acute care settings, to advance patient triage, diagnosis, and access to care.

Dr. Zègre-Hemsey is an emergency department nurse with a PhD in Nursing from the University of California, San Francisco (UCSF). She is also an adult-gerontology clinical nurse specialist (CNS) with a focus on critical-care trauma. Dr. Zègre-Hemsey holds an adjunct faculty appointment in the UNC School of Medicine, Department of Emergency Medicine.

Treasurer

Salah Shafiq Al-Zaiti, PhD, RN, FAHA
University of Pittsburgh

Dr. Salah Al-Zaiti is an Associate Professor of Nursing, Emergency Medicine, and Cardiology at University of Pittsburgh. His research interests align at the intersection of cardiovascular sciences, biomedical modeling, and machine learning. Over the past 10 years, Dr. Al-Zaiti has contributed to the scientific investigation of more than dozen studies and has more than 100 scholarly publications. His current research at UPMC focuses on novel computational ECG markers of myocardial ischemia. Dr. Al-Zaiti currently serves as the principal investigator of an NHLBI-funded study to develop machine learning-based ECG methods that can detect biomarker evidence of non-ST elevation myocardial necrosis in patients with prehospital chest pain. On a parallel line of research, Dr. Al-Zaiti also aims to explore the role of ischemic preconditioning, apoptosis, and autophagy during acute myocardial injury.

2026 Annual Conference Chair

.

2026 Annual Conference Co-Chair

.

Member
Immediate Past President
ISE Liaison

Jean-Philippe Couderc, PhD, MBA
University of Rochester

Dr. Jean-Philippe Couderc has dedicated his career to quantitative electrocardiography focusing on the development and application of novel techniques for the analysis of ventricular repolarization from the surface ECG in human and in various animal models for clinical trials. He is a founder and director of the Telemetric and Holter ECG Warehouse, a partnership between the U.S. Food and Drug Administration and the University of Rochester. The THEW serves as a platform for industry, academia and regulators to validate new methods for advancing the science and practice of conducting cardiac safety studies. He is the author or co-author of numerous publications in computational science and engineering, numerical analysis, and computer science applied to electrophysiological signals. Jean-Philippe is currently a member of the editorial boards of the Annals of Non-Invasive Electrocardiology and holds a Special Government Employee position at the Center for Drug Evaluation and Research for the FDA. He has participated in a wide range of clinical trials as well as being principal investigator and a co-investigator in several federally-funded research grants. Jean-Philippe is a frequent lecturer at universities, laboratories, and industrial research centers in U.S and Europe involving industry and national agencies like the National Institutes of Health and the Environmental Protection Agency. He obtained his PhD degree with highest honors from the French National Institute of Applied Sciences in Lyon, France and was appointed Associate Professor of Medicine in the Cardiology Department of Strong Memorial Hospital at the University of Rochester Medical Center. Jean-Philippe also has an MBA from University of Rochester’s Simon Business School. He is Assistant Director of the Heart Research Follow-up Program Laboratory, an international leader in the research of the long QT syndrome.

Director

Eric Helfenbein
Phillips Healthcare

Director

Director

Johannes de Bie, Johan for short, has worked in Bologna, Italy for most of his career at Mortara Instrument Inc., as part of the Engineering Management team and later as Senior Vice President of Global Engineering. In the last six years before retiring, he was Chief Scientific Officer at Mortara Instrument Inc., later Hillrom / Baxter, where he was leading a team in the development of algorithms for ECG analysis and multi-parameter Patient Monitoring.

During his 30 year tenure, Johan has contributed to many developments and validation efforts in the company, and authored or co-authored numerous publications, often in cooperation with scientific institutions. He coached numerous students from the University of Bologna during his time at Mortara and co-hosted the 2008 edition of the annual “Computing in Cardiology” conference in Bologna, Italy, and participated in the organization of the 2020 Rimini edition.

His six years working in the Leiden University Medical Center before his industrial career has, apart from spawning his passion for the ECG, ingrained in him the firm belief that intelligent tools HAVE to be clinically useful, for the caregiver and the patient alike. His education at the Delft University of Technology in the Netherlands, where he took his MSc and PhD in Applied Physics taught him the scientific integrity that is at the basis of quality products.

Johan’s specialties are clinical use cases of ECG’s, ECG and vital signs monitoring, ECG-related algorithm development, Device-Human Interfaces and Usability, Medical Device standards and Risk Analysis, Project management, Technical Communication, Healthcare and Drug Trial Workflows.

After his retirement Johan took up a part time position as Adjunct Professor at the University of Bologna where he is teaching students on the design of medical devices, as well as doing paid and unpaid consulting for medical device companies and university research teams.

Director

Dr. Roger Abächerli, PhD
Lucerne University of Applied Sciences and Arts

Dr. Roger Abächerli (PhD) is working at the Lucerne University of Applied Sciences and Art (HSLU). Before that, he worked for more than 15 years in the MedTech industry in different positions mainly in R&D, latest as global head of biomedical research and signal processing before switching to academia. He has graduated as an Electrical Engineer from the Swiss Federal Institute of Technology Lausanne (EPFL) while doing exchange studies at the Georgia Institute of Technology (GaTech- Atlanta, USA), and University College of Dublin (UCD -Ireland). He got his PhD from the Department of Radiology at the Centre Hospitalier Universitaire (CHU) de Nancy and from the National Polytechnic Institute of Lorraine (INPL), Nancy in France. His work has been recognized with national and international awards. He has published more than 30 peer-reviewed scientific articles, among half of them as first or last author and among one third in so called high rank journals. He holds nine patents and helped developing several medical devices in different field of MedTech including the field of electrocardiology. He currently is involved in research projects such as cardiac REHA, mammography and chronic pain reduction in paraplegics using virtual walking.

He is a specialist in the new European Medical Device Regulation (EU-MDR) related to product development especially in high-end signal processing such as AI/ML. He is senior member of the IEEE, is elected fellow of the American Heart Association (AHA), the European Society of Cardiology (ESC), the European Heart and Rhythm Association (EHRA) and the American College of Cardiology (ACC). Moreover, he recently became a member of the Swiss Academy of Engineering Sciences (SATW).

Director

Patrick Noffke

Patrick Noffke has been in engineering since 1997.  He began his career developing intelligent control systems for commercial printing presses, designing optics, electronics, and image processing algorithms to overcome engineering challenges in harsh environments.  In 2014, he joined Mortara Instrument, Inc. where he designed embedded software and algorithms for electrocardiograph devices, and helped develop international safety standards as a member of the AAMI/EC ECG committee.  In 2025, Patrick joined Catheter Precision, Inc. as Director of Engineering.  Throughout his career, he was granted over a dozen patents.

Patrick received a B.S. in physics and mathematics from Carroll College in 1995 and is currently pursuing a Ph.D. in biomedical engineering from Marquette University and the Medical College of Wisconsin, with a focus on computational electrophysiology modeling of the fetal ventricular cardiomyocyte.

Director

.

Director

Ramun Schmid

Ramun Schmid holds a Bachelor of Science in Electrical Engineering and a Master of Science in Engineering from the Applied University of Eastern Switzerland, where he specialized in digital signal processing. Early in his career, he completed a traineeship at St. Jude Medical AB in Sweden, which sparked his ongoing interest in biomedical technologies.

From 2010 to 2011, Ramun worked at the Institute for Communication Systems (ICOM) in Rapperswil, before joining Schiller AG in Baar, Switzerland. Over the years, he has developed deep expertise in ECG signal processing, contributing to advancements in filtering techniques, data-driven interpretation algorithms, and non-invasive blood pressure analysis. His work spans both traditional digital signal processing methods and state-of-the-art deep learning approaches, always with a focus on clinical relevance and practical application.

Currently, Ramun leads the algorithm development team at Schiller AG, where he manages projects in cooperation with academic and clinical partners. His collaborative work with universities and hospitals continues to enhance the diagnostic capabilities of a range of medical devices.

In parallel with his industry role, Ramun serves as a lecturer in biosignal processing at the Lucerne University of Applied Sciences and Arts (HSLU), where he shares his knowledge and experience with the next generation of engineers.

Director

J Randall Moorman

J Randall Moorman J Randall Moorman, a clinical cardiologist, is Bicentennial Professor of Advanced Medical Analytics Medicine at the University of Virginia.

He received the MD degree in 1978 from the University of Mississippi and trained in Internal Medicine and Cardiology at Duke University, where he was Chief Medical Resident at Duke Hospital in 1982-3. He trained in molecular electrophysiology and membrane biophysics at Baylor College of Medicine from 1985 to 1990, when he joined the faculty of the University of Virginia where he was clinically active on in-patient and out-patient cardiology consultant services until 2020.

In 2014, he was named UVa Innovator of the Year. In 2017, he gave the keynote address at the meeting of the Association for the Advancement of Medical Instrumentation. In 2017, he became the inaugural director of the UVa Center for Advanced Medical Analytics Engineering, which intends to lead the field in how data advance healthcare. From 2013 to 2019, he was Editor-in-Chief of Physiological Measurement, an Institute of Physics Publishing journal with international readership and authorship. He has mentored more than 40 trainees in basic and clinical research; nearly half have academic appointments. He is currently a Principal Investigator on three NIH grants.

He has published about 200 full-length peer-reviewed papers in journals including Nature, Science, Physical Review Letters, Journal of Clinical Investigation, Journal of General Physiology, Biophysical Journal, Circulation, Circulation Research, and Critical Care Medicine. His h-index is 48 in Web of Science and 61 in Google Scholar. With JS Richman, he described sample entropy, a variant of Kolmogorov-Sinai entropy that is a general test for nonlinear dynamical systems. The paper has been cited >5000 times in Web of Science and >7500 times in Google Scholar and is in the top 10 most-cited scientific papers with only UVa authors.

The overarching hypothesis of the past 20 years of work is that subacute potentially catastrophic illnesses have prodromal signatures in the physiological monitoring data. A robust example is the abnormal heart rate characteristics of reduced variability and transient decelerations prior to neonatal sepsis. He developed mathematical techniques to characterize these, related them to clinical findings, and developed the heart rate characteristics index. This is the fold-increase in risk relative to average of the diagnosis of neonatal sepsis in the next 24 hours. He was the Principal Investigator of the largest individually randomized clinical trial ever of premature infants, showing that display of the monitor and no mandated clinical intervention led to improved survival, especially in the 25% of infants who developed sepsis, where mortality was reduced from 20% to 12%. In 2018, this was named one of the top 12 research discoveries in the past 50 years at the University of Virginia. Since 2014, he and his coworkers have applied these concepts and approaches to adult illness in the hospitalized patient.